Federal investigators seek tighter regulation of drug advertising
Washington, D.C. - Direct-to-consumer (DTC) advertising of prescription drugs is growing and is boosting spending on pharmaceuticals, so the Food and Drug Administration (FDA) needs to pick up the pace to remove false or misleading commercials from the air. Those are the main conclusions of a landmark report on DTC advertising from Congress' General Accounting Office ("FDA Oversight of Direct-to-Consumer Advertising Has Limitations," available at www.gao.gov).
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Lifts Safety Restrictions on CAR T Therapies After Reviewing Real-World Data
July 2nd 2025FDA officials have determined that information regarding the risks for six CAR T-cell therapies can be communicated through product labeling, which includes a boxed warning for the risks of cytokine release syndrome and neurological toxicities.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
